451 related articles for article (PubMed ID: 18985950)
41. Civilian Health and Medical Program of the Uniformed Services (CHAMPUS)/TRICARE; partial implementation of Pharmacy Benefits Program; implementation of National Defense Authorization Act Medical Benefits for fiscal year 2001. Office of the Secretary, DoD. Interim final rule.
Fed Regist; 2001 Feb; 66(28):9651-8. PubMed ID: 11503862
[TBL] [Abstract][Full Text] [Related]
42. Adding choice to Medicare.
Olsen GG
Rehab Manag; 2004 Mar; 17(2):50-2. PubMed ID: 15022501
[No Abstract] [Full Text] [Related]
43. What a Food and Drug lawyer should know about the Medicare Modernization Act.
Azar AM
Food Drug Law J; 2004; 59(2):217-22. PubMed ID: 15318393
[No Abstract] [Full Text] [Related]
44. Medicare prescription drugs and reform: what the new law will mean to gastroenterologists and their patients.
Fise T
Am J Gastroenterol; 2004 May; 99(5):775-6. PubMed ID: 15128335
[No Abstract] [Full Text] [Related]
45. Rising cap rates offer big upside in Medicare Advantage plans.
Capitation Rates Data; 2004 Aug; 9(8):85-9. PubMed ID: 15487582
[No Abstract] [Full Text] [Related]
46. Medicare prescription drug plans: the impact on physician practice.
Marable S
Med Health R I; 2006 Jan; 89(1):39-40. PubMed ID: 16519205
[No Abstract] [Full Text] [Related]
47. Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; policies, requirements, and administrative procedures; delay of effective date; reopening of administrative record. Food and Drug Administration, HHS. Final rule; delay of effective date; reopening of administrative record.
Fed Regist; 2000 May; 65(86):25639-41. PubMed ID: 11010689
[TBL] [Abstract][Full Text] [Related]
48. Medicare drugs.
Poisal JA
Health Care Financ Rev; 2003; 25(2):1-5. PubMed ID: 15124373
[TBL] [Abstract][Full Text] [Related]
49. The new Medicare Advantage a disadvantage for providers?
O'Hare PK
Healthc Financ Manage; 2004 Mar; 58(3):36-40. PubMed ID: 15029797
[TBL] [Abstract][Full Text] [Related]
50. Medicare Part D: an overview of its practical and clinical impact.
Usdin S
Am J Geriatr Cardiol; 2005; 14(6):284-8; quiz 289-90. PubMed ID: 16276124
[TBL] [Abstract][Full Text] [Related]
51. Congressional healthcare outlook: prescription drugs.
Graham SB
Hosp Outlook; 2001 Jul; 4(5):6, 12. PubMed ID: 11478182
[No Abstract] [Full Text] [Related]
52. Medicare should bargain for lower drug prices, study says.
Med Health; 2005 Oct; 59(36):1, 3, 7. PubMed ID: 16240494
[No Abstract] [Full Text] [Related]
53. A bitter pill: the new Medicare prescription drug benefit.
Siegel S
Health Care Law Mon; 2005 Mar; ():3-9. PubMed ID: 15818780
[No Abstract] [Full Text] [Related]
54. Prescription drugs in Medicare and the ESRD program.
Powe NR
Semin Nephrol; 2000 Nov; 20(6):535-42. PubMed ID: 11111855
[TBL] [Abstract][Full Text] [Related]
55. More than the drug benefit.
Olsen GG
Rehab Manag; 2004 Apr; 17(3):42-4. PubMed ID: 15067925
[No Abstract] [Full Text] [Related]
56. United States pharmacopeia development of the Medicare model formulary guidelines.
Bielory L;
Am J Geriatr Cardiol; 2005; 14(6):301-7. PubMed ID: 16276127
[TBL] [Abstract][Full Text] [Related]
57. Medicare program; manufacturer submission of manufacturer's average sales price (ASP) data for Medicare Part B drugs and biologicals. Final rule.
Centers for Medicare & Medicaid Services (CMS), HHS
Fed Regist; 2004 Sep; 69(179):55763-5. PubMed ID: 15372731
[TBL] [Abstract][Full Text] [Related]
58. Lost in the doughnut hole. The drug benefit's woes will worsen as seniors discover shortcomings.
Sloane T
Mod Healthc; 2006 Jan; 36(3):24. PubMed ID: 16445210
[No Abstract] [Full Text] [Related]
59. Nine health plans drop Medicare markets. AAHP President Karen Ignagni said HCFA has 'put this program into crisis'.
Shinkman R
Mod Healthc; 1999 Jul; 29(27):3, 10. PubMed ID: 10538946
[No Abstract] [Full Text] [Related]
60. MMA reviews prescription drug plans.
Minn Med; 2000 Jan; 83(1):35-6. PubMed ID: 10680430
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
